Mild hyperhomocyst(e)inemia - A possible risk factor for cervical artery dissection

被引:78
作者
Gallai, V
Caso, V
Paciaroni, M
Cardaioli, G
Arning, E
Bottiglieri, T
Parnetti, L
机构
[1] Univ Perugia, Dept Neurosci, I-06126 Perugia, Italy
[2] Baylor Univ, Med Ctr, Inst Metab Dis, Dallas, TX USA
关键词
amine oxidoreductases; dissection; homocyst(e)ine; stroke; ultrasonography;
D O I
10.1161/01.STR.32.3.714
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The pathogenesis of cervical artery dissection (CAD) remains unknown in most cases. Hyperhomocyst(e)inemia [hyperH(e)], an independent risk factor for cerebrovascular disease, induces damage in endothelial cells in animal cell culture. Consecutive patients with CAD and age-matched control subjects have been studied by serum levels of homocyst(e)ine and the genotype of 5,10-methylenetetrahydrofolate reductase (MTHFR). Methods-Twenty-six patients with CAD, admitted to our Stroke Unit (15 men and 11 women; 16 vertebral arteries, 10 internal carotid arteries), were compared with age-matched control subjects. All patients underwent duplex ultrasound, MR angiography, and/or conventional angiography, Results-Mean plasma homocyst(e)ine level was 17.88 mu mol/L (range 5.95 to 40.0 mu mol/L) for patients with CAD and 6.0+/-0.99 mu mol/L for controls (P<0.001). The genetic analysis for the thermolabile form of MTHFR in CAD patients showed heterozygosity in 54% and homozygosity in 27%; comparable figures for controls were 40% (P=0.4) and 10% (P=0.1), respectively. Conclusions-Mild hyperH(e) might represent a risk factor for cervical artery dissection. The MTHFR mutation is not significantly associated with CAD. An interaction between different genetic and environmental factors probably takes place in the cascade of pathogenetic events leading to arterial wall damage.
引用
收藏
页码:714 / 718
页数:5
相关论文
共 42 条
[11]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[12]   Plasma homocysteine as a risk factor for vascular disease - The European concerted action project [J].
Graham, IM ;
Daly, LE ;
Refsum, HM ;
Robinson, K ;
Brattstrom, LE ;
Ueland, PM ;
PalmaReis, RJ ;
Boers, GHJ ;
Sheahan, RG ;
Israelsson, B ;
Uiterwaal, CS ;
Meleady, R ;
McMaster, D ;
Verhoef, P ;
Witteman, J ;
Rubba, P ;
Bellet, H ;
Wautrecht, JC ;
deValk, HW ;
Luis, ACS ;
ParrotRoulaud, FM ;
Tan, KS ;
Higgins, I ;
Garcon, D ;
Medrano, MJ ;
Candito, M ;
Evans, AE ;
Andria, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1775-1781
[13]   What level of plasma homocyst(e)ine should be treated?: Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L [J].
Hackam, DG ;
Peterson, JC ;
Spence, JD .
AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (01) :105-110
[14]   HOMOCYSTINEMIA - VASCULAR INJURY AND ARTERIAL THROMBOSIS [J].
HARKER, LA ;
SLICHTER, SJ ;
SCOTT, CR ;
ROSS, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (11) :537-543
[15]   HOMOCYSTINE-INDUCED ARTERIOSCLEROSIS - ROLE OF ENDOTHELIAL CELL INJURY AND PLATELET RESPONSE IN ITS GENESIS [J].
HARKER, LA ;
ROSS, R ;
SLICHTER, SJ ;
SCOTT, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (03) :731-741
[16]   DISSECTIONS [J].
HART, RG ;
EASTON, JD .
STROKE, 1985, 16 (06) :925-927
[17]   Genetics and ischaemic stroke [J].
Hassan, A ;
Markus, HS .
BRAIN, 2000, 123 :1784-1812
[18]   Measurement of blood flow in the vertebral artery using colour duplex Doppler ultrasound: establishment of the reliability of selected parameters [J].
Johnson, C ;
Grant, R ;
Dansie, B ;
Taylor, J ;
Spyropolous, P .
MANUAL THERAPY, 2000, 5 (01) :21-29
[19]  
KANG SS, 1991, AM J HUM GENET, V48, P536
[20]  
Kirsch E, 1998, NEURORADIOLOGY, V40, P704